NO20015278L - 6-alkenyl-, 6-alkynyl- og 6-epoksy-epotilonderivater, fremgangsmåte for deres fremstilling og deres anvendelse ifarmasöytiske preparater - Google Patents

6-alkenyl-, 6-alkynyl- og 6-epoksy-epotilonderivater, fremgangsmåte for deres fremstilling og deres anvendelse ifarmasöytiske preparater

Info

Publication number: NO20015278L
Authority: NO; Norway
Prior art keywords: alkynyl; alkenyl; epoxy; preparation; pharmaceutical preparations
Prior art date: 1999-04-30

Application number

NO20015278A

Other languages

English (en)

Other versions

NO20015278D0 (no

NO328149B1 (no

Inventor

Ulrich Klar

Wolfgang Schwede

Werner Skuballa

Bernd Buchmann

Jens Hoffmann

Rosemarie Lichtner

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-30

Filing date

2001-10-29

Publication date

2001-12-21

1999-04-30 Priority claimed from DE19921086A external-priority patent/DE19921086A1/de

1999-11-04 Priority claimed from DE19954228A external-priority patent/DE19954228A1/de

2000-03-27 Priority claimed from DE10015836A external-priority patent/DE10015836A1/de

2001-10-29 Application filed by Schering Ag filed Critical Schering Ag

2001-10-29 Publication of NO20015278D0 publication Critical patent/NO20015278D0/no

2001-12-21 Publication of NO20015278L publication Critical patent/NO20015278L/no

2009-12-21 Publication of NO328149B1 publication Critical patent/NO328149B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20015278A 1999-04-30 2001-10-29 Epoksy-epotilonforbindelser, fremgangsmate for deres fremstilling, deres anvendelse for fremstilling av farmasoytiske preparater og de farmasoytiske preparater. NO328149B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE19921086A DE19921086A1 (de)	1999-04-30	1999-04-30	6-Alkenyl- und 6-Alkinyl-Epothilon Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
DE19954228A DE19954228A1 (de)	1999-11-04	1999-11-04	6-Alkenyl-und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
DE10015836A DE10015836A1 (de)	2000-03-27	2000-03-27	6-Alkenyl- und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
PCT/IB2000/000657 WO2000066589A1 (en)	1999-04-30	2000-05-01	6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations

Publications (3)

Publication Number	Publication Date
NO20015278D0 NO20015278D0 (no)	2001-10-29
NO20015278L true NO20015278L (no)	2001-12-21
NO328149B1 NO328149B1 (no)	2009-12-21

Family

ID=27213767

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20015278A NO328149B1 (no)	1999-04-30	2001-10-29	Epoksy-epotilonforbindelser, fremgangsmate for deres fremstilling, deres anvendelse for fremstilling av farmasoytiske preparater og de farmasoytiske preparater.

Country Status (33)

Country	Link
EP (1)	EP1173441B1 (no)
JP (2)	JP4024003B2 (no)
KR (1)	KR100721488B1 (no)
CN (1)	CN100368415C (no)
AR (1)	AR023792A1 (no)
AT (1)	ATE440847T1 (no)
BG (1)	BG65601B1 (no)
BR (1)	BR0010190A (no)
CA (2)	CA2651653C (no)
CY (1)	CY1109768T1 (no)
CZ (1)	CZ299653B6 (no)
DE (1)	DE60042821D1 (no)
DK (1)	DK1173441T3 (no)
EA (1)	EA011502B1 (no)
EE (1)	EE05292B1 (no)
ES (1)	ES2331506T3 (no)
HK (1)	HK1046681B (no)
HR (1)	HRP20010892A2 (no)
HU (1)	HUP0201010A3 (no)
IL (1)	IL145938A0 (no)
ME (1)	MEP13908A (no)
MX (1)	MXPA01011039A (no)
NO (1)	NO328149B1 (no)
NZ (1)	NZ514989A (no)
PE (1)	PE20010116A1 (no)
PL (1)	PL210762B1 (no)
PT (1)	PT1173441E (no)
RS (1)	RS51023B (no)
SI (1)	SI1173441T1 (no)
SK (1)	SK286858B6 (no)
TW (2)	TWI280962B (no)
WO (1)	WO2000066589A1 (no)
ZA (1)	ZA200109859B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0873341T3 (da)	1995-11-17	2004-01-19	Biotechnolog Forschung Gmbh	Epothilonderivater, fremstilling og anvendelse
WO1998022461A1 (de)	1996-11-18	1998-05-28	GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF)	Epothilone c, d, e und f, deren herstellung und deren verwendung als cytostatische mittel bzw. als pflanzenschutzmittel
US6204388B1 (en)	1996-12-03	2001-03-20	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
WO1999001124A1 (en)	1996-12-03	1999-01-14	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6605599B1 (en)	1997-07-08	2003-08-12	Bristol-Myers Squibb Company	Epothilone derivatives
US6365749B1 (en)	1997-12-04	2002-04-02	Bristol-Myers Squibb Company	Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6498257B1 (en)	1998-04-21	2002-12-24	Bristol-Myers Squibb Company	2,3-olefinic epothilone derivatives
US6399638B1 (en)	1998-04-21	2002-06-04	Bristol-Myers Squibb Company	12,13-modified epothilone derivatives
US6518421B1 (en)	2000-03-20	2003-02-11	Bristol-Myers Squibb Company	Process for the preparation of epothilone analogs
US6593115B2 (en)	2000-03-24	2003-07-15	Bristol-Myers Squibb Co.	Preparation of epothilone intermediates
DE10020899A1 (de) *	2000-04-20	2001-10-25	Schering Ag	9-Oxa-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
UA75365C2 (en) *	2000-08-16	2006-04-17	Bristol Myers Squibb Co	Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
BRPI0206509B8 (pt)	2001-01-25	2021-05-25	R Pharm Us Operating Llc	processo para formular, para administração parenteral, um análogo de epotilona, preparação farmacêutica, processo para formar uma composição farmacêutica para administração parental, composição farmacêutica e uso de um análogo de epotilona na preparação de uma composição farmacêutica para o tratamento de câncer
NZ526871A (en)	2001-01-25	2006-01-27	Bristol Myers Squibb Co	Pharmaceutical dosage forms of epothilones for oral administration
CA2434566A1 (en)	2001-01-25	2002-08-15	Timothy M. Malloy	Parenteral formulation containing epothilone analogs
PL363363A1 (en)	2001-02-20	2004-11-15	Bristol-Myers Squibb Company	Epothilone derivatives for the treatment of refractory tumors
PL363362A1 (en)	2001-02-20	2004-11-15	Bristol-Myers Squibb Company	Treatment of refractory tumors using epothilone derivatives
EP1383490B1 (en)	2001-03-14	2012-04-25	Bristol-Myers Squibb Company	Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
US6800653B2 (en)	2001-06-01	2004-10-05	Bristol-Myers Squibb Compnay	Epothilone derivatives
EP1340498A1 (en) *	2002-03-01	2003-09-03	Schering Aktiengesellschaft	Use of epothilones in the treatment of brain diseases associated with proliferative processes
WO2003077903A1 (en)	2002-03-12	2003-09-25	Bristol-Myers Squibb Company	C12-cyano epothilone derivatives
DK1483251T3 (da)	2002-03-12	2010-04-12	Bristol Myers Squibb Co	C3-cyano-epothilon-derivater
TW200403994A (en)	2002-04-04	2004-03-16	Bristol Myers Squibb Co	Oral administration of EPOTHILONES
TW200400191A (en)	2002-05-15	2004-01-01	Bristol Myers Squibb Co	Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
AU2003243561A1 (en)	2002-06-14	2003-12-31	Bristol-Myers Squibb Company	Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
PL375902A1 (en)	2002-09-23	2005-12-12	Bristol-Myers Squibb Company	Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b
DE10361794B3 (de) *	2003-12-31	2005-10-06	Schering Ag	Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese
EP1559447A1 (en)	2004-01-30	2005-08-03	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
EP1640004A1 (en) *	2004-09-24	2006-03-29	Schering Aktiengesellschaft	Use of epothilones in the treatment of bone metastases and bone tumors or cancers
US20060121511A1 (en)	2004-11-30	2006-06-08	Hyerim Lee	Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
EP1674098A1 (en) *	2004-12-23	2006-06-28	Schering Aktiengesellschaft	Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water
CN100384419C (zh) *	2005-12-02	2008-04-30	菏泽睿鹰制药集团有限公司	一种埃坡霉素缓释植入组合物及应用
DE102007016046A1 (de)	2007-03-30	2008-10-23	Bayer Schering Pharma Aktiengesellschaft	Verfahren zur Herstellung von Epothilonderivaten durch selektive katalytische Epoxidierung
EP2065054A1 (en)	2007-11-29	2009-06-03	Bayer Schering Pharma Aktiengesellschaft	Combinations comprising a prostaglandin and uses thereof
EP2070521A1 (en)	2007-12-10	2009-06-17	Bayer Schering Pharma Aktiengesellschaft	Surface-modified nanoparticles
DE102007059752A1 (de)	2007-12-10	2009-06-18	Bayer Schering Pharma Aktiengesellschaft	Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone
EP2210584A1 (en)	2009-01-27	2010-07-28	Bayer Schering Pharma Aktiengesellschaft	Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
JP5881254B2 (ja)	2010-05-18	2016-03-09	セルリアン・ファーマ・インコーポレイテッド	自己免疫疾患およびその他の疾患の治療のための組成物および方法
EP2793949B1 (en)	2011-12-23	2018-08-22	Innate Pharma	Enzymatic conjugation of antibodies
WO2014009426A2 (en)	2012-07-13	2014-01-16	Innate Pharma	Screening of conjugated antibodies
EP2916872B1 (en)	2012-11-09	2019-02-27	Innate Pharma	Recognition tags for tgase-mediated conjugation
WO2014140300A1 (en)	2013-03-15	2014-09-18	Innate Pharma	Solid phase tgase-mediated conjugation of antibodies
WO2014202773A1 (en)	2013-06-20	2014-12-24	Innate Pharma	Enzymatic conjugation of polypeptides
CA2914189C (en)	2013-06-21	2023-03-14	Innate Pharma	Enzymatic conjugation of polypeptides
WO2019092148A1 (en)	2017-11-10	2019-05-16	Innate Pharma	Antibodies with functionalized glutamine residues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS54115320A (en) *	1978-02-28	1979-09-07	Soda Aromatic	Novel unsaturated keto acid and its manufacture
JP2653663B2 (ja) *	1988-02-15	1997-09-17	財団法人微生物化学研究会	１．３―ジヒドロキシ―８―デセン―５―オンを含む免疫賦活剤及び制癌剤
EP0469480A3 (en) *	1990-08-01	1993-03-10	Hoechst Aktiengesellschaft	Process for stereoselective preparation of 5-substituted delta-lactones and their use
DE59805110D1 (de) *	1997-02-25	2002-09-12	Biotechnolog Forschung Gmbh	Seitenkettenmodifizierte epothilone
CA2299608A1 (en) *	1997-08-09	1999-02-18	Schering Aktiengesellschaft	New epothilone derivatives, method for producing same and their pharmaceutical use

2000
- 2000-04-28 PE PE2000000403A patent/PE20010116A1/es not_active Application Discontinuation
- 2000-04-28 AR ARP000102024A patent/AR023792A1/es active IP Right Grant
- 2000-05-01 BR BR0010190-7A patent/BR0010190A/pt not_active IP Right Cessation
- 2000-05-01 CA CA2651653A patent/CA2651653C/en not_active Expired - Fee Related
- 2000-05-01 PT PT00922826T patent/PT1173441E/pt unknown
- 2000-05-01 MX MXPA01011039A patent/MXPA01011039A/es active IP Right Grant
- 2000-05-01 AT AT00922826T patent/ATE440847T1/de active
- 2000-05-01 EA EA200101025A patent/EA011502B1/ru not_active IP Right Cessation
- 2000-05-01 EE EEP200100568A patent/EE05292B1/xx not_active IP Right Cessation
- 2000-05-01 PL PL351491A patent/PL210762B1/pl not_active IP Right Cessation
- 2000-05-01 NZ NZ514989A patent/NZ514989A/xx not_active IP Right Cessation
- 2000-05-01 JP JP2000615619A patent/JP4024003B2/ja not_active Expired - Fee Related
- 2000-05-01 RS YUP-776/01A patent/RS51023B/sr unknown
- 2000-05-01 ME MEP-139/08A patent/MEP13908A/xx unknown
- 2000-05-01 DE DE60042821T patent/DE60042821D1/de not_active Expired - Lifetime
- 2000-05-01 HR HR20010892A patent/HRP20010892A2/xx not_active Application Discontinuation
- 2000-05-01 HU HU0201010A patent/HUP0201010A3/hu unknown
- 2000-05-01 WO PCT/IB2000/000657 patent/WO2000066589A1/en not_active Ceased
- 2000-05-01 IL IL14593800A patent/IL145938A0/xx unknown
- 2000-05-01 ES ES00922826T patent/ES2331506T3/es not_active Expired - Lifetime
- 2000-05-01 CN CNB008069786A patent/CN100368415C/zh not_active Expired - Fee Related
- 2000-05-01 CZ CZ20013885A patent/CZ299653B6/cs not_active IP Right Cessation
- 2000-05-01 SK SK1551-2001A patent/SK286858B6/sk not_active IP Right Cessation
- 2000-05-01 DK DK00922826T patent/DK1173441T3/da active
- 2000-05-01 SI SI200031044T patent/SI1173441T1/sl unknown
- 2000-05-01 KR KR1020017013840A patent/KR100721488B1/ko not_active Expired - Fee Related
- 2000-05-01 HK HK02108204.3A patent/HK1046681B/zh not_active IP Right Cessation
- 2000-05-01 EP EP00922826A patent/EP1173441B1/en not_active Expired - Lifetime
- 2000-05-01 CA CA2371226A patent/CA2371226C/en not_active Expired - Fee Related
- 2000-05-18 TW TW89108133A patent/TWI280962B/zh not_active IP Right Cessation
- 2000-05-18 TW TW095145399A patent/TWI294292B/zh not_active IP Right Cessation
2001
- 2001-10-26 BG BG106053A patent/BG65601B1/bg unknown
- 2001-10-29 NO NO20015278A patent/NO328149B1/no not_active IP Right Cessation
- 2001-11-29 ZA ZA200109859A patent/ZA200109859B/xx unknown
2007
- 2007-04-11 JP JP2007104224A patent/JP4886578B2/ja not_active Expired - Fee Related
2009
- 2009-11-25 CY CY20091101237T patent/CY1109768T1/el unknown

Also Published As

Publication number	Publication date
HUP0201010A2 (en)	2002-08-28
AR023792A1 (es)	2002-09-04
YU77601A (sh)	2005-07-19
EE200100568A (et)	2003-02-17
EA200101025A1 (ru)	2002-06-27
HK1046681B (zh)	2008-08-29
EA011502B1 (ru)	2009-04-28
BG106053A (en)	2002-05-31
CA2651653C (en)	2012-02-14
MXPA01011039A (es)	2003-06-30
DK1173441T3 (da)	2009-12-07
KR100721488B1 (ko)	2007-05-23
JP4886578B2 (ja)	2012-02-29
ES2331506T3 (es)	2010-01-07
BR0010190A (pt)	2002-01-08
PL210762B1 (pl)	2012-02-29
PE20010116A1 (es)	2001-02-15
SI1173441T1 (sl)	2010-01-29
WO2000066589A1 (en)	2000-11-09
TWI280962B (en)	2007-05-11
JP2002543203A (ja)	2002-12-17
PT1173441E (pt)	2009-11-06
NO20015278D0 (no)	2001-10-29
MEP13908A (en)	2010-06-10
CA2371226A1 (en)	2000-11-09
TWI294292B (en)	2008-03-11
DE60042821D1 (de)	2009-10-08
ZA200109859B (en)	2003-02-28
EP1173441A1 (en)	2002-01-23
JP4024003B2 (ja)	2007-12-19
IL145938A0 (en)	2002-07-25
CN1349534A (zh)	2002-05-15
PL351491A1 (en)	2003-04-22
CZ299653B6 (cs)	2008-10-08
KR20020005737A (ko)	2002-01-17
SK15512001A3 (sk)	2002-05-09
CY1109768T1 (el)	2014-09-10
BG65601B1 (bg)	2009-02-27
CA2371226C (en)	2011-11-29
EE05292B1 (et)	2010-04-15
CN100368415C (zh)	2008-02-13
SK286858B6 (sk)	2009-06-05
NZ514989A (en)	2004-02-27
TW200711679A (en)	2007-04-01
HK1046681A1 (zh)	2003-01-24
ATE440847T1 (de)	2009-09-15
HRP20010892A2 (hr)	2008-06-30
CA2651653A1 (en)	2000-11-09
NO328149B1 (no)	2009-12-21
CZ20013885A3 (cs)	2002-04-17
HUP0201010A3 (en)	2005-02-28
JP2007224038A (ja)	2007-09-06
EP1173441B1 (en)	2009-08-26
RS51023B (sr)	2010-10-31

Publication	Publication Date	Title
NO20015278L (no)	2001-12-21	6-alkenyl-, 6-alkynyl- og 6-epoksy-epotilonderivater, fremgangsmåte for deres fremstilling og deres anvendelse ifarmasöytiske preparater
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
NO20012567D0 (no)	2001-05-25	Azepinoindolderivater, fremstilling og anvendelse derav
EE05109B1 (et)	2008-12-15	Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
NO963506D0 (no)	1996-08-22	4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
DK1345910T3 (da)	2009-07-20	Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO924650D0 (no)	1992-12-02	Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
DK1161434T3 (da)	2003-05-26	Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
EE200100422A (et)	2002-12-16	Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
IS6420A (is)	2002-06-13	Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun
DK1043307T3 (da)	2003-09-22	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20016247D0 (no)	2001-12-19	Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO20016404L (no)	2002-03-01	Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20022022D0 (no)	2002-04-29	N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20001905D0 (no)	2000-04-12	Forbindelser og deres anvendelse i farmasøytiske eller kosmetiske preparater
NO20025028L (no)	2002-10-18	9-oksa-epotilonderivater, fremgangsmÕte for fremstilling derav samt deres anvendelse i farmasöytiske preparater
NO20013878L (no)	2001-10-10	(1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme
DK1086077T3 (da)	2004-08-02	Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
NO20000066D0 (no)	2000-01-06	6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO20013141D0 (no)	2001-06-22	Arylalkanoylderivater, fremgangsmåte for fremstilling derav, deres anvendelse og farmasöytiske produkter inneholdende disse
NO20020777L (no)	2002-02-15	Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
DK1183241T3 (da)	2004-01-19	Spiroimidazolidinderivater, deres præparation, deres anvendelse og farmaceutiske præparationer omfattende disse
NO20001782L (no)	2000-10-09	3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20022482L (no)	2002-07-24	2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav

Legal Events

Date	Code	Title	Description
2013-02-11	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE
2013-12-23	MM1K	Lapsed by not paying the annual fees